In this case study, we consider a double blind randomized phase III study in infectious disease. More than 5000 patients were randomized across 150 sites from 18 countries. A total 400 variables were collected in the CRF. A run of CluePoints was performed at the beginning of the follow - up period to detect any atypical site behavior and associated patient data issues.